Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca-headquarters_low_res

AstraZeneca’s second quarter beats estimates

July 31, 2014
Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer

AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …

News
Proteus digital pill

‘Smart pill’ creator gains new funding

July 31, 2014
Medical Communications, Research and Development, Sales and Marketing digital medicine, proteus, smart pills

Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients …

News

Cause of rare childhood cancer discovered

July 31, 2014
Research and Development, Sales and Marketing Cancer, RMS, YAP, childhood cancer

Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Around 60 …

News
tim_tonic

Tonic expands leadership team with two new hires

July 31, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Tonic Life Communications, the PR arm for Huntsworth Health, has added Tracey Carey as its new head of consumer and …

Appointment
celgene_1_02_1

NICE won’t back Revlimid in new setting

July 31, 2014
Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma

NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …

News
David Cameron PM

Dementia diagnoses on the rise

July 30, 2014
Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia

The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …

News
steven_bradshaw

MKTXS appoints Dr Steven Bradshaw as director

July 30, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …

Appointment

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …

News
Amgen HQ

Amgen to wield axe on 2,900 jobs

July 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …

News
Pfizer New York HQ

Pfizer revenue drops, but new cancer drugs shine

July 29, 2014
Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra

Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …

News
atorvastatin

Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014
Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …

News
Roche

Roche’s blood cancer drug gains EU approval

July 29, 2014
Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche

The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …

News
renee_mellas_23

Healthcare marketer Renée Mellas re-joins Area 23 as MD

July 29, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FCS Health

Healthcare and pharma marketing professional Renée Mellas has returned to Area  23, an FCB Health company, as executive vice president …

Appointment

US doctor infected with Ebola as disease spreads

July 28, 2014
Medical Communications, Sales and Marketing Ebola, WHO

An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …

News
google_plaque

Google hopes DNA search will yield health results

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens

Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …

News
european_flag

Europe warned over cancer research risk

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …

News
EMA HQ

EMA approvals for rival blood cancer drugs

July 27, 2014
Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig

Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …

News
sovaldi_ariad_sofosbuvir_bottle_1

NHS England’s Sovaldi fund: opening the floodgates?

July 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

Feature
malaria_vaccine_trial_0

GSK seeks regulatory review of first malaria vaccine

July 26, 2014
Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, malaria, rts, s

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …

News

More action needed on antibiotic resistance

July 25, 2014
Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026